Abiopharma

NeuroPace Announces Strategic CFO Transition

New Form 3 - NEOGENOMICS INC Filed: 2025-06-24 AccNo: 0001077183-25-000146 Size: 372 KB

New Form 424B3 - Oric Pharmaceuticals, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145721 Size: 200 KB

New Form 4 - Twist Bioscience Corp Filed: 2025-06-24 AccNo: 0001214659-25-009547 Size: 5 KB

New Form 4 - Keros Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-062092 Size: 21 KB

New Form 4 - Twist Bioscience Corp Filed: 2025-06-24 AccNo: 0001214659-25-009548 Size: 5 KB

New Form 4 - Twist Bioscience Corp Filed: 2025-06-24 AccNo: 0001214659-25-009549 Size: 12 KB

New Form 144 - AGIOS PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001900772-25-000003 Size: 4 KB

BioVie Inc. - BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & RelatedDisorders® Congress

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium

Spider-Man: Beyond the Spider-Verse – Everything We Know So Far

11-K (Annual Report of Employee Stock Plans) SEC Filing

New Form DEFA14A - Rein Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145714 Size: 16 KB

New Form 8-K - MIRA PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001641172-25-016285 Size: 209 KB Item 8.01: Other Events

New Form 144 - AGIOS PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001900772-25-000002 Size: 4 KB